[{"address1": "55 Claverick Street", "address2": "Room 325", "city": "Providence", "state": "RI", "zip": "02903", "country": "United States", "phone": "401 444 7375", "website": "https://www.oceanbiomedical.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company's oncology product candidates include OCX-253 anti-Chi3l1 Single-target mAb and OCX-410 anti-Chi3l1/PD-1 Bi-specific antibody for the treatment of non-small cell lung cancer; and OCX-909 anti-Chi3l1/CTLA-4 Bi-specific antibody to treat glioblastoma multiforme. Its fibrosis product candidates consist of OCF-203 anti-Chit1 small molecule for the treatment of idiopathic pulmonary fibrosis (IPF) and hermansky-pudlak syndrome (HPS). The company's infectious diseases product candidates for malaria include the ODA-570 vaccine for the prevention of P. falciparum infection; ODA-611 anti-PfGARP mAb for the treatment of Symptomatic P. falciparum infection; and ODA-579 anti-PfGARP small molecule for the treatment of Symptomatic P. falciparum infection. It has license agreement with Elkurt, Inc. for FRG Antibody, bi-specific antibody anti-CTLA4, bispecific (FRG)x anti-PD-1 (FRGxPD-1), chit1 small molecule antifibrotic, and malaria small molecules and antibodies. The company was founded in 2019 and is based in Providence, Rhode Island. Ocean Biomedical, Inc. is a subsidiary of Poseidon Bio, LLC.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. Inderjote  Kathuria M.B.A., M.D.", "age": 56, "title": "Chief Strategy Officer", "yearBorn": 1968, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chirinjeev Baboo Kathuria M.B.A., M.D.", "age": 59, "title": "Founder & Executive Chairman of the Board", "yearBorn": 1965, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jolie G. Kahn CPA, Esq.", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1965, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.008, "open": 0.0076, "dayLow": 0.0068, "dayHigh": 0.0078, "regularMarketPreviousClose": 0.008, "regularMarketOpen": 0.0076, "regularMarketDayLow": 0.0068, "regularMarketDayHigh": 0.0078, "payoutRatio": 0.0, "beta": 1.504, "forwardPE": -0.008988765, "volume": 431686, "regularMarketVolume": 431686, "averageVolume": 14377277, "averageVolume10days": 2149850, "averageDailyVolume10Day": 2149850, "bid": 0.0075, "ask": 0.0079, "bidSize": 149385, "askSize": 166653, "marketCap": 1858920, "fiftyTwoWeekLow": 0.005, "fiftyTwoWeekHigh": 1.45, "fiftyDayAverage": 0.0084, "twoHundredDayAverage": 0.357725, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "profitMargins": 0.0, "floatShares": 208405973, "sharesOutstanding": 232364992, "sharesShort": 2930195, "sharesShortPriorMonth": 5719851, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0177, "heldPercentInsiders": 0.10311, "heldPercentInstitutions": 0.02001, "shortRatio": 0.05, "shortPercentOfFloat": 0.020499999, "impliedSharesOutstanding": 232364992, "bookValue": -0.557, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -30719000, "trailingEps": -0.91, "forwardEps": -0.89, "52WeekChange": -0.99292034, "SandP52WeekChange": 0.1116153, "quoteType": "EQUITY", "currentPrice": 0.008, "recommendationKey": "none", "totalDebt": 15352000, "currentRatio": 0.056, "returnOnAssets": -1.14869, "freeCashflow": -5344625, "operatingCashflow": -4051000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "OCEA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1636381800000, "regularMarketChange": 0.0, "regularMarketDayRange": "0.0068 - 0.0078", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 14377277, "fiftyTwoWeekLowChange": 0.0030000005, "fiftyTwoWeekLowChangePercent": 0.6000001, "fiftyTwoWeekRange": "0.005 - 1.45", "fiftyTwoWeekHighChange": -1.442, "fiftyTwoWeekHighChangePercent": -0.99448276, "fiftyTwoWeekChangePercent": -99.29203, "earningsTimestampStart": 1744115400, "earningsTimestampEnd": 1744115400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.91, "epsForward": -0.89, "fiftyDayAverageChange": -0.00039999932, "fiftyDayAverageChangePercent": -0.04761897, "twoHundredDayAverageChange": -0.349725, "twoHundredDayAverageChangePercent": -0.9776365, "priceToBook": -0.014362658, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "marketState": "CLOSED", "shortName": "Ocean Biomediacal, Inc.", "longName": "Ocean Biomedical, Inc.", "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1752264000, "exchange": "PNK", "messageBoardId": "finmb_669640055", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.008, "displayName": "Ocean Biomedical", "trailingPegRatio": null, "__fetch_time": "2025-07-12"}]